Overview
Adam Kibel is a Urologist in Boston, Massachusetts. Dr. Kibel is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Kibel is currently accepting new patients.
His clinical research consists of co-authoring 401 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Muscle Invasive Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
Locations
450 Brookline Ave, Boston, MA 02215
45 Francis St, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.
The General Hospital Corporation
Matthew Wszolek is a Urologist in Danvers, Massachusetts. Dr. Wszolek is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Kibel isElite. Learn about Bladder Cancer.
- CystectomyDr. Kibel isElite. Learn about Cystectomy.
- Familial Prostate CancerDr. Kibel isElite. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Kibel isElite. Learn about Prostate Cancer.
- ProstatectomyDr. Kibel isElite. Learn about Prostatectomy.
- Distinguished
- Familial Wilms Tumor 2Dr. Kibel isDistinguished. Learn about Familial Wilms Tumor 2.
- LymphadenectomyDr. Kibel isDistinguished. Learn about Lymphadenectomy.
- Muscle Invasive Bladder CancerDr. Kibel isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Kibel isDistinguished. Learn about Nephrectomy.
- Renal Cell Carcinoma (RCC)Dr. Kibel isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Kibel isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Chromophobe Renal Cell Carcinoma
- Clear Cell SarcomaDr. Kibel isAdvanced. Learn about Clear Cell Sarcoma.
- Non-Muscle Invasive Bladder Cancer
- Upper Tract Urothelial Carcinoma (UTUC)
- VasectomyDr. Kibel isAdvanced. Learn about Vasectomy.
- Venous Thromboembolism (VTE)Dr. Kibel isAdvanced. Learn about Venous Thromboembolism (VTE).
- Experienced
- EndoscopyDr. Kibel isExperienced. Learn about Endoscopy.
- Enlarged Prostate (BPH)Dr. Kibel isExperienced. Learn about Enlarged Prostate (BPH).
- Erectile Dysfunction (ED)Dr. Kibel isExperienced. Learn about Erectile Dysfunction (ED).
- HydroceleDr. Kibel isExperienced. Learn about Hydrocele.
- MalakoplakiaDr. Kibel isExperienced. Learn about Malakoplakia.
- OrchiectomyDr. Kibel isExperienced. Learn about Orchiectomy.

